Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.3 HKD | +1.10% | +7.67% | -13.75% |
Apr. 26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
Business Summary
Number of employees: 3,615
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research, Service and Production
100.0
%
| - | - | 1,189 | 100.0 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.5
%
| 843 | 94.1 % | 1,159 | 97.5 % | +37.60% |
United States
2.5
%
| 53 | 5.9 % | 30 | 2.5 % | -43.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jian Min Fang
CEO | Chief Executive Officer | 62 | 08-07-03 |
Shao Jing Tong
DFI | Director of Finance/CFO | 53 | 23-09-27 |
Ruyi He
CTO | Chief Tech/Sci/R&D Officer | 63 | 20-05-10 |
Wei Liang
IRC | Investor Relations Contact | 41 | - |
Pak Yu Tam
SEC | Corporate Secretary | - | 20-05-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xian Jing Hao
BRD | Director/Board Member | 59 | 20-05-10 |
Yun Jin Chen
BRD | Director/Board Member | 39 | 22-05-04 |
Jian Min Fang
CEO | Chief Executive Officer | 62 | 08-07-03 |
Ruyi He
CTO | Chief Tech/Sci/R&D Officer | 63 | 20-05-10 |
Jian Lin
BRD | Director/Board Member | 69 | 08-07-03 |
Liqiang Wang
BRD | Director/Board Member | 54 | 20-05-10 |
Wei Dong Wang
FOU | Founder | 65 | 08-07-03 |
Ren Guangke
CHM | Chairman | 51 | 20-05-10 |
Li Zhuan Glin
BRD | Director/Board Member | 50 | 20-05-10 |
Lan Ma
BRD | Director/Board Member | 66 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 354,750,844 | 135,780,346 ( 38.27 %) | 0 | 55.32 % |
Stock B | 1 | 189,581,239 | 165,352,198 ( 87.22 %) | 6,418,330 ( 3.386 %) |
Company contact information
RemeGen Co., Ltd.
No. 58, Beijing Middle Road Yantai Development Zone
264006, Yantai
+86 53 5611 3513
http://www.remegen.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.75% | 3.55B | |
+2.54% | 108B | |
+9.78% | 105B | |
+0.15% | 23.46B | |
-12.49% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.47% | 17.19B | |
+6.12% | 13.99B | |
+35.22% | 12.53B |
- Stock Market
- Equities
- 9995 Stock
- Company RemeGen Co., Ltd.